[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355237-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355237-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","melatonin-inhibits-fak-signaling-to-suppress-pd-l1-expression-and-enhance-chemosensitivity-in-triple-negative-breast-cancer","Melatonin inhibits FAK signaling to suppress PD-L1 expression and enhance chemosensitivity in triple-negative breast cancer","","Triple-negative breast cancer (TNBC) is an aggressive subtype with limited targeted options, so chemotherapy remains central despite toxicity and resistance. This study evaluates serum melatonin in TNBC patients versus healthy controls and tests melatonin effects in TNBC cell lines and an orthotopic 4T1 mouse model. Melatonin lowers tumor-promoting behaviors by inhibiting FAK signaling and PD-L1, increases apoptosis, and enhances cisplatin chemosensitivity, while in vivo it suppresses growth and remodels the immune microenvironment by boosting CD8+ infiltration and reducing FOXP3+ regulatory T cells.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/melatonin-inhibits-fak-signaling-to-suppress-pd-l1-expression-and-enhance-chemosensitivity-in-triple-negative-breast-cancer/355237/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/melatonin-inhibits-fak-signaling-to-suppress-pd-l1-expression-and-enhance-chemosensitivity-in-triple-negative-breast-cancer/355237.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main finding about melatonin levels in TNBC patients?","Question",{"text":63,"@type":64},"TNBC patients show significantly lower serum melatonin levels than healthy controls.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which molecular pathway does melatonin affect in the study?",{"text":68,"@type":64},"Melatonin inhibits focal adhesion kinase (FAK) signaling, which suppresses PD-L1 expression.",{"name":70,"@type":61,"acceptedAnswer":71},"How does melatonin influence treatment response and the tumor immune microenvironment?",{"text":72,"@type":64},"Melatonin enhances chemosensitivity to cisplatin and suppresses tumor growth in vivo, while increasing CD8+ T-cell infiltration and decreasing FOXP3+ regulatory T cells and PD-L1 in the tumor microenvironment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355237,1790638769,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Ivyspring  \nInternational Publisher  \nInternationalJournal of Medical Sciences  \n2026; 23(3): 876-888. doi: 10.7150/ijms.127669  \nResearch Paper  \nMelatonin inhibits FAK signaling to suppress PD-L1 expression and enhance chemosensitivity in triple-negative breast cancer  \nCheng-Che Wu1,2†, Ping-Fu Yang1†, Shu-Jyuan Chang3†, Mei-Ren Pan2,3, Chung-Liang Li1, Chun-Chieh Wu4, Jung-Yu Kan1, Fang-Ming Chen1, Ming-Feng Hou1,5, Chi-Wen Luo1,5,6􀀍  \n1. Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.  \n2. Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.  \n3. Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.  \n4. Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.  \n5. Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.  \n6. Department of Cosmetic Science and Institute of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.  \n†Contributed equally to this work.  \n􀀍 Corresponding author: Chi-Wen Luo, Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Tel.: +886-7-3121101 ext. 2260, Fax: +886-7-3165011; E-mail: [cwlo0623@gmail.com](cwlo0623@gmail.com).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.11.01; Accepted: 2026.01.16; Published: 2026.01.30  \nAbstract  \nBackground: Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targetable hormone receptors, making conventional chemotherapy the primary treatment option, despite its associated toxicity and potential for drug resistance. Melatonin, a natural hormone with anticancer and immunomodulatory properties, has shown promise in multiple cancers; however, its role in TNBC remains unclear.  \nMethods: We analyzed serum melatonin levels in TNBC patients and healthy controls. The biological effects of melatonin were then evaluated in human (MDA-MB-231, MDA-MB-468) and murine (4T1) TNBC cell lines. In vitro assays assessed proliferation, apoptosis, migration, epithelial–mesenchymal transition (EMT), and chemosensitization. Mechanistic pathways were analyzed, and an orthotopic 4T1 syngeneic mouse model was employed to confirm antitumor and immunomodulatory effects in vivo. Results: We found that TNBC patients had significantly lower serum melatonin levels than healthy controls. In vitro, melatonin reduced cell viability, migration, and tumorsphere formation, and promoted apoptosis. Mechanistically, it downregulated focal adhesion kinase (FAK) and programmed death-ligand 1 (PD-L1). FAK inhibition increased melatonin sensitivity, whereas FAK overexpression conferred resistance. Melatonin also enhanced cisplatin cytotoxicity. In vivo, melatonin treatment suppressed tumor growth, increased CD8⁺ T-cell infiltration, and decreased PD-L1 expression and the number of FOXP3⁺ regulatory T cells in the tumor microenvironment.  \nConclusions: Melatonin suppresses TNBC progression by inhibiting proliferation and migration and by modulating the immune microenvironment through the FAK–PD-L1 axis. These findings highlight melatonin as a potential low-toxicity adjunct to enhance the efficacy of current TNBC therapies.  \nKeywords: Triple-negative breast cancer, melatonin, immune modulation, focal adhesion kinase (FAK), programmed death-ligand 1 (PD-L1)  \nIntroduction  \nBreast cancer is the most frequently diagnosed cancer and a leading cause of cancer-related mortality  \namong women worldwide [1] . Molecular classification is based ","cbCaiiL6ZQtxMVQv","https://ap.wps.com/l/cbCaiiL6ZQtxMVQv","pdf",7903983,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Melatonin in cancer and immune modulation","[{\"question\":\"What is the main finding about melatonin levels in TNBC patients?\",\"answer\":\"TNBC patients show significantly lower serum melatonin levels than healthy controls.\"},{\"question\":\"Which molecular pathway does melatonin affect in the study?\",\"answer\":\"Melatonin inhibits focal adhesion kinase (FAK) signaling, which suppresses PD-L1 expression.\"},{\"question\":\"How does melatonin influence treatment response and the tumor immune microenvironment?\",\"answer\":\"Melatonin enhances chemosensitivity to cisplatin and suppresses tumor growth in vivo, while increasing CD8+ T-cell infiltration and decreasing FOXP3+ regulatory T cells and PD-L1 in the tumor microenvironment.\"}]","Melatonin inhibits FAK signaling to suppress PD-L1 expression and enhance chemosensitivity in triple-negative breast cancer | PDF",1790116962,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/109d5478ad5972cd834003752925e79b.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eddf2278bb8beb12cfa21e55d0a58034.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b00b46c424f8a234bca903e04151e55b.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd92d4ff87a80d58a2f87a995749c639.webp",980,1268]